This parasitic disease, known as the tsetse fly, permanently threatens 60 million people in Africa. This new treatment could eliminate the transmission of sleeping sickness by 2030.
The drug was developed by Sanofi and a research organization founded by the World Health Organization. Illustrative photo. (AFP)
A drug, acoziborole, developed by Sanofi and a research organization founded by the World Health Organization (WHO), can cure sleeping sickness, reveals the medical journal The Lancet. This parasitic disease, known as the tsetse fly, permanently threatens 60 million people in Africa.
There are treatments for human African trypanosomiasis, otherwise known as sleeping sickness, but they usually require hospitalization. This parasite invades the nervous system, causing in particular sleep disorders, before causing death.
Several tablets of this new drug, acoziborole, swallowed at once can cure. It is 95% effective a year and a half after taking the treatment, according to The Lancet. This drug eliminates the parasite in humans. It could eliminate the transmission of sleeping sickness by 2030.
woodworkers.com, alpilean.com, exipure.com, amazonian.com, prodentim.com, ikariajuice.com, fluxactIve.com, glucotrust.com, soulmate.com